SequelSEC

VitaNova Life Sciences Corp VNOV

Wholesale-Apparel, Piece Goods & Notions · CIK 0001699709 · Fiscal year ends 0430

AnnualQuarterlyTTM
Revenue
$3.24M
Fiscal year ended 2026-07-31
Operating income
-$86.12K
Fiscal year ended 2026-07-31
Free cash flow
Unavailable
Fiscal year ended 2026-07-31

Valuation, from the filing

Public float$24.12MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-10-31
Float per share$2.89Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue8.0×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity11.8×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-10-31, not today, and each multiple below it uses the figures for the fiscal year ending 2026-04-30 — the year that filing covered.

How this compares in its industry

Percentile among the Wholesale-Apparel, Piece Goods & Notions filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Gross margin30.1%25th

VitaNova Life Sciences Corp (VNOV) reported revenue of $3.24M and net income of -$114.10K for the fiscal year ended 2026-07-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from VitaNova Life Sciences Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Wholesale-Apparel, Piece Goods & Notions.

Income

VitaNova Life Sciences Corp income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Revenue$3.24M
Cost of revenue$2.37M
Gross profit$872.33K
Operating income-$86.12K
Net income-$114.10K
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expense$30.96K
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$782.33K
Selling & marketingUnavailable

Balance

VitaNova Life Sciences Corp balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Cash & equivalentsUnavailable
Total assets$2.24M
Current assets$2.22M
Total liabilities$311.66K
Current liabilities$311.66K
Total equity incl. NCI$1.93M
Temporary (mezzanine) equityUnavailable
Inventory$301.29K
Accounts receivable$316.87K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$122.80K

Cash flow

VitaNova Life Sciences Corp cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Operating cash flow$557.56K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flowUnavailable
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

VitaNova Life Sciences Corp derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Free cash flowUnavailable
Gross margin26.9%
Operating margin-2.7%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio7.13x
Revenue YoY growth22.0%
Net margin-3.5%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open VNOV in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-09-14View SEC filing
10-K · Filed 2026-07-29View SEC filing
10-Q · Filed 2026-03-16View SEC filing
10-Q · Filed 2025-12-15View SEC filing
10-Q · Filed 2025-09-12View SEC filing
10-K · Filed 2025-07-24View SEC filing

Companies in the same industry

AHRO KMFG SKFG WEYS

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.